Summary
- Indoco Remedies Limited has finalized a slump sale agreement to transfer its ophthalmic business to Sunways (India) Private Limited for ₹110 crore.
- The transaction positions Sunways to enhance its portfolio in the ophthalmic sector while Indoco focuses on its core operations.
- Lakshmikumaran & Sridharan Attorneys provided legal counsel to Indoco Remedies throughout this deal.
- This strategic move could reshape the competitive landscape in the ophthalmic market in India.
Join the discussion — sign up to comment, upvote, and save articles.